Inbrija Prices, Coupons, Copay Cards & Patient Assistance
Inbrija (levodopa) is a member of the dopaminergic antiparkinsonism agents drug class and is commonly used for Parkinson's Disease.
Inbrija is available as a brand name drug only, a generic version is not yet available. View generic Inbrija availability for more details.
Inbrija prices
Inhalation Capsule
42 mg Inbrija inhalation capsule from $1,260.45 for 60 capsules
| Quantity | Per unit | Price |
|---|---|---|
| 60 (15 x 4 each) | $21.01 | $1,260.45 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Inbrija Coupons, Copay Cards and Rebates
Inbrija offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Inbrija $0 Co-Pay Program
Eligible commercially insured patients may pay $0 for their first prescription (up to five 30-dose cartons) and then pay $30 for each subsequent monthly prescription.
- Applies to:
- Inbrija
- Number of uses:
- Per prescription until program expires
Form more information phone: 888-887-3447 or Visit website
Inbrija Direct Cash Purchase Program
Eligible cash-paying patients may pay $195 per carton.
- Applies to:
- Inbrija
- Number of uses:
- Per prescription until program expires
Form more information phone: 888-887-3447 or Visit website
Patient Assistance & Copay Programs for Inbrija
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Inbrija (levodopa) Powder; Inhalation
More information please phone: 866-316-7263 Visit website
Provider: Prescription Support Services: Inbrija
Eligibility requirements:- Contact program for details.
- Determined case by case
- Medically Necessary as determined by a Doctor
- US residency requirements are not specified.
- Co-payment assistance, and patient assistance programs are available for eligible patients.
- Inbrija (levodopa) Powder; Inhalation
More information please phone: 888-887-3447 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Inbrija (levodopa)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español